FTC, Wholesalers Amend AndroGel Complaints
The Federal Trade Commission and three drug wholesalers representing buyers of the testosterone supplement AndroGel have filed second amended complaints in their suits against several drugmakers claiming patent settlements over the...To view the full article, register now.
Already a subscriber? Click here to view full article